Literature DB >> 15895303

Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors.

Y Balash1, C Peretz, G Leibovich, T Herman, J M Hausdorff, N Giladi.   

Abstract

Falls are one of the most serious complications of gait disturbances in patients with Parkinson's disease (PD). Among previous reports, the percentage of patients with PD who fall varies between 38% to 68%. We sought to determine the frequency of falls and the factors associated with falls in a group of patients with idiopathic PD who attended an outpatient, tertiary movement disorders clinic. 350 ambulatory, non-demented patients (230 males) were studied. Mean age was 69.7+/-10.6 years (range: 43-97 yrs) and mean duration of PD symptoms was 8.6+/- 6.2 years (range: 1-33 yrs). Assessments included characterization of demographics, disease duration, disease severity as measured by the Hoehn and Yahr Scale (H&amp;Y), co-morbidities, the presence of depressive symptoms, the presence of urinary incontinence, use of anti-parkinsonian medications, and two performance-based tests of balance and gait (tandem standing and Timed Up &amp; Go). Fall history was determined during three time periods: previous week, previous month, and previous year. Univariate and multivariate logistic regression models were applied to evaluate the relationship between the above-mentioned factors and falls. 46% of the subjects reported at least one fall in the previous year and 33% reported 2 or more falls and were classified as Fallers. Fallers had significantly more prolonged and advanced PD compared with Non-fallers (p=0.001 and p<0.001, respectively). Urinary incontinence was the factor most closely associated with falls (crude and adjusted OR were 1.95 and 5.89, respectively). Other factors significantly associated with fall status included increased Timed Up &amp; Go times and increased PD duration. These findings confirm that falls are a common problem among patients with advanced PD and suggest easily measurable features that may be used to prospectively identify those PD patients with the greatest risk of falls.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895303     DOI: 10.1007/s00415-005-0855-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  A community-dwelling sample of people with Parkinson's disease: characteristics of fallers and non-fallers.

Authors:  A Ashburn; E Stack; R M Pickering; C D Ward
Journal:  Age Ageing       Date:  2001-01       Impact factor: 10.668

2.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

3.  Prospective assessment of falls in Parkinson's disease.

Authors:  B R Bloem; Y A Grimbergen; M Cramer; M Willemsen; A H Zwinderman
Journal:  J Neurol       Date:  2001-11       Impact factor: 4.849

4.  Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease.

Authors:  Y Sato; S Manabe; H Kuno; K Oizumi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group.

Authors:  J S Brown; E Vittinghoff; J F Wyman; K L Stone; M C Nevitt; K E Ensrud; D Grady
Journal:  J Am Geriatr Soc       Date:  2000-07       Impact factor: 5.562

Review 7.  Comorbidities associated with overactive bladder.

Authors:  J S Brown; W F McGhan; S Chokroverty
Journal:  Am J Manag Care       Date:  2000-07       Impact factor: 2.229

8.  Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study.

Authors:  B H Wood; J A Bilclough; A Bowron; R W Walker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

9.  Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.

Authors:  Ira Shoulson; David Oakes; Stanley Fahn; Anthony Lang; J William Langston; Peter LeWitt; C Warren Olanow; John B Penney; Caroline Tanner; Karl Kieburtz; Alice Rudolph
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

10.  Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group.

Authors:  J S Uebersax; J F Wyman; S A Shumaker; D K McClish; J A Fantl
Journal:  Neurourol Urodyn       Date:  1995       Impact factor: 2.696

View more
  65 in total

1.  Utility of the Mini-BESTest, BESTest, and BESTest sections for balance assessments in individuals with Parkinson disease.

Authors:  Abigail L Leddy; Beth E Crowner; Gammon M Earhart
Journal:  J Neurol Phys Ther       Date:  2011-06       Impact factor: 3.649

2.  Impaired step up/over in persons with Parkinson's disease.

Authors:  Joe R Nocera; Michael Horvat; Christopher T Ray
Journal:  Adapt Phys Activ Q       Date:  2010-04       Impact factor: 2.929

3.  Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis.

Authors:  Stewart A Factor; N Kyle Steenland; Donald S Higgins; Eric S Molho; Denise M Kay; Jennifer Montimurro; Ami R Rosen; Cyrus P Zabetian; Haydeh Payami
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-30       Impact factor: 10.154

Review 4.  Gait dynamics in Parkinson's disease: common and distinct behavior among stride length, gait variability, and fractal-like scaling.

Authors:  Jeffrey M Hausdorff
Journal:  Chaos       Date:  2009-06       Impact factor: 3.642

5.  External validation of a simple clinical tool used to predict falls in people with Parkinson disease.

Authors:  Ryan P Duncan; James T Cavanaugh; Gammon M Earhart; Terry D Ellis; Matthew P Ford; K Bo Foreman; Abigail L Leddy; Serene S Paul; Colleen G Canning; Anne Thackeray; Leland E Dibble
Journal:  Parkinsonism Relat Disord       Date:  2015-05-16       Impact factor: 4.891

Review 6.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

7.  The Mini-BESTest is an independent predictor of falls in Parkinson Disease.

Authors:  Larissa Karlla Rodrigues Lopes; Aline Alvim Scianni; Lidiane Oliveira Lima; Raquel de Carvalho Lana; Fátima Rodrigues-De-Paula
Journal:  Braz J Phys Ther       Date:  2019-07-25       Impact factor: 3.377

Review 8.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

Review 9.  Treadmill training for the treatment of gait disturbances in people with Parkinson's disease: a mini-review.

Authors:  T Herman; N Giladi; J M Hausdorff
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

10.  Assessment of fall-related self-efficacy and activity avoidance in people with Parkinson's disease.

Authors:  Maria H Nilsson; Anna-Maria Drake; Peter Hagell
Journal:  BMC Geriatr       Date:  2010-10-25       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.